Policy | August 27, 2025
Indian pharma resilient to US tariffs; Eyes US pricing reform gains: Ind-Ra
The US generic market is crucial for Indian pharma, contributing about 35% to its total revenue, around US$ 10.7 billion
The US generic market is crucial for Indian pharma, contributing about 35% to its total revenue, around US$ 10.7 billion
OGSIVEO is the first and only therapy to receive marketing authorization in the EU for the treatment of desmoid tumors
The therapy delivers the full-length ABCA4 protein and has the potential to benefit all patients with ABCA4 mutations
Plant-based chemistries have an outsized role to play for the HPC sector by meeting demand for good, gentle, and green products
The campaign celebrates radiant, healthy skin that shines naturally, empowering women to step forward with confidence in every walk of life.
LEQSELVI now available for prescription in U.S. nationwide, offering a new option for eligible patients
The company received one observation in the Form-483
The company received 1 (One) observation in the Form-483
Honeywell Aclar film technology will enable Evertis to develop high-quality barrier packaging solutions
Ingredion will have exclusive access to Amyris’ technology to manufacture and sell fermented Reb M
Subscribe To Our Newsletter & Stay Updated
